Dr. Hans Mueller Joins Easton Capital Investment Group Scientific Advisory Board.

NEW YORK -- Easton Capital Investment Group, a New York-based venture capital firm, today announced that Dr. Hans Mueller has joined its Scientific Advisory Board. Dr. Mueller has more than 35 years of experience in the pharmaceutical industry, having managed and led several hundred major transactions

over the span of his distinguished career. Until 2004, Dr. Mueller was the Senior Vice President of Global Business Development at Wyeth Pharmaceuticals. Currently, Dr. Mueller provides consulting services for HM Consulting and three additional VC-funded health care companies.

John H. Friedman, founder and managing partner of Easton Capital, said, "We are honored to have Dr. Mueller join our Scientific Advisory Board. His depth of knowledge and extensive experience in the pharmaceutical industry will help support our current portfolio of life sciences businesses, and his counsel will be an invaluable competitive advantage as we continue to invest in this high-growth field."

Accepting the appointment, Dr. Mueller said, "Easton Capital has achieved significant success in the life science industry and has assembled a sophisticated and talented Scientific Advisory Board. I am proud to join such an esteemed group of researchers and physicians, and I hope to carry on their strong tradition of providing budding companies with the tools and resources they need to bring new innovations to the health care marketplace and, ultimately, to see their businesses flourish."

As Senior Vice President at Wyeth Pharmaceuticals, Dr. Mueller was responsible for worldwide licensing, partnerships, collaborations and divestitures and served on several key management committees. Prior to joining Wyeth, he was president and a member of the Board of Directors of Nova Pharmaceuticals, a company he helped transform from a small research boutique to a multi-million dollar enterprise. Previously, Dr. Mueller held a series of positions at Sandoz Ltd. and Sandoz Inc. in research, regulatory affairs, manufacturing, systems development, new product planning, licensing and business development.

Dr. Mueller is a graduate of Harvard Business School's Advanced Management Program and holds a Ph.D. in Actuarial Sciences and Mathematical Statistics with an undergraduate degree in Mathematics, Finance and Economy. He has lectured at the University of Bern, Switzerland. Dr. Mueller is a board member of an American Stock Exchange-traded company and three VC-funded health care companies.